Trailing-twelve-month (TTM) revenue is $2.39 Billion with a year-over-year growth of +24.09%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-09-30 | $515,751,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q1 FY2026Period ended 2025-12-31 | $511,959,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-28 |
| Q2 FY2026Period ended 2026-03-31 | $691,677,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-28 |
| Q3 FY2026Period ended 2026-06-30 | $674,188,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-29 |
| TTM revenue | $2,393,575,000 |
Current P/S: $21,282,094,538 market capitalization ÷ $2,393,575,000 TTM revenue = 8.89x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-06-30): $674.19M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:31.898Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-09-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-09-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-30 · USD | FY20212021-09-30 · USD | FY20222022-09-30 · USD | FY20232023-09-30 · USD | FY20242024-09-30 · USD | FY20252025-09-30 · USD |
|---|---|---|---|---|---|---|
| Applications | N/A | N/A | N/A | N/A | N/A | $822M |
| Scores | $529M | $654M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-30 · USD | FY20212021-09-30 · USD | FY20222022-09-30 · USD | FY20232023-09-30 · USD | FY20242024-09-30 · USD | FY20252025-09-30 · USD |
|---|---|---|---|---|---|---|
| Americas | N/A | $1.0B | $1.1B | $1.3B | $1.4B | $1.7B |
| Asia Pacific | $99M | $76M | $99M | $85M |
$2.39B
$2.39 Billion
+24.09%
vs. $1.93B a year ago (TTM)
+12.03%
5 Year compound annual growth rate
1 Year
+24.09%
3 Year
+17.57%
5 Year
+12.03%
10 Year
+10.55%
15 Year
+9.49%
20 Year
+5.49%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.99B | +$273.34M | +15.91% |
| 2024 | $1.72B | +$203.97M | +13.48% |
| 2023 | $1.51B | +$136.29M | +9.90% |
| 2022 | $1.38B | +$60.73M | +4.61% |
| 2021 | $1.32B | +$21.97M | +1.70% |
| 2020 |
TTM Growth
+24.09%
3-Year CAGR
+17.57%
5-Year CAGR
+12.03%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:31.898Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $774M |
| $920M |
| $1.2B |
| Software | N/A | $662M | $671M | $740M | $798M | N/A |
|---|
| $98M |
| $99M |
| EMEA | $204M | $190M | $147M | $141M | $170M | $160M |
|---|
| Latin America | $62M | N/A | N/A | N/A | N/A | N/A |
|---|
| North America | $930M | N/A | N/A | N/A | N/A | N/A |
|---|
| $1.29B |
| +$134.48M |
| +11.59% |
| 2019 | $1.16B | +$127.61M | +12.36% |
| 2018 | $1.03B | +$100.31M | +10.76% |
| 2017 | $932.17M | +$50.81M | +5.77% |
| 2016 | $881.36M | +$42.58M | +5.08% |
